Immune, endocrine, and behavioral precursors to breast cancer recurrence: A case-control analysis

Cancer Immunology, Immunotherapy

Volumn 57, Issue 10, 2008, Pages 1471-1481

  Thornton, Lisa M ^a   Andersen, Barbara L ^a,b   Carson III, William E ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Breast neoplasms; Fatigue; Granulocytes; Inflammation; Leukocytes; Neoplasm metastasis

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SURGERY; CASE CONTROL STUDY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; QUALITY OF LIFE;

ADRENOCORTICOTROPIC HORMONE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOTOXICITY, IMMUNOLOGIC; DEPRESSION; EPINEPHRINE; FATIGUE; FEMALE; HUMANS; HYDROCORTISONE; LEUKOCYTE COUNT; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NOREPINEPHRINE; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL;

EID: 48149099100     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0485-6     Document Type: Article

References (37)

1. SPSS 14.0 for Windows. Release 14.0.0. SPSS, Inc, Chicago
2. American Joint Committee on Cancer (1997) AJCC cancer staging manual. Lippincott-Raven, Philadelphia
3. American Joint Committee on Cancer (2002) AJCC cancer staging manual. In: Greene FL (ed). Springer, New York
4. BL Andersen WB Farrar DM Golden-Kreutz 2007 Distress reduction from a psychological intervention contributes to improved health for cancer patients Brain Behav Immun 7 953 961
5. BL Andersen WB Farrar DM Golden-Kreutz 2004 Psychological, behavioral, and immune changes following a psychosocial intervention: a clinical trial J Clin Oncol 17 1 3570 3580
6. H Anisman S Hayley N Turrin 2002 Cytokines as a stressor: implications for depressive illness Int J Neuropsychopharmacol 5 4 357 373
7. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545
8. J Bryant R Day TL Whiteside 1992 Calculation of lytic units for the expression of cell-mediated cytotoxicity J Immunol Methods 146 1 91 103
9. M Colozza E Azambuja F Cardoso 2005 Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann Oncol 16 11 1723 1739
10. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 6917 860 867
11. R Demicheli MW Retsky DE Swartzendruber 1997 Proposal for a new model of breast cancer metastatic development Ann Oncol 8 11 1075 1080
12. R Demicheli M Terenziani G Bonadonna 1998 Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up? Breast Cancer Res Treat 51 2 133 137
13. E di Carlo M Iezzi T Pannellini 2001 Neutrophils in anti-cancer immunological strategies: old players in new games J Hematother Stem Cell Res 10 6 739 748
14. M Furihata H Sonobe Y Ohtsuki 1999 An immunohistochemical study on a case of granulocyte-colony stimulating factor-producing gall-bladder carcinoma Pathol Int 49 11 1010 1013
15. K Imai S Matsuyama S Miyake 2000 Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population Lancet 356 Nov 25 1795 1799
16. M Inoue M Minami Y Fujii 1997 Granulocyte colony-stimulating factor and interleukin-6-producing lung cancer cell line, LCAM J Surg Oncol 64 4 347 350
17. M Jakobisiak W Lasek J Golab 2003 Natural mechanisms protecting against cancer Immunol Lett 90 2-3 103 122
18. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 199-205
19. Kee JL (2005) Laboratory and diagnostic tests. Pearson Education, Upper Saddle River
20. SM Levy RB Herberman M Lippman 1991 Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer Behav Med 17 67 75
21. SM Levy BD Wise 1987 Psychosocial risk factors, natural immunity, and cancer progression: Implications for intervention Health Psychol 6 3 229 43
22. McNair DM, Lorr M, Droppleman LF (1971) EITS manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
23. CM Moinpour P Feigl B Metch 1989 Quality of life end points in cancer clinical trials: Review and recommendations J Natl Cancer Inst 81 7 485 495
24. GR Morrow PL Andrews JT Hickok 2002 Fatigue associated with cancer and its treatment Support Care Cancer 10 389 398
25. ID Nagtegaal CA Marijnen EK Kranenbarg 2001 Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect-a histopathological and immunohistochemical study BMC Cancer 1 7
26. L Norton 1988 A Gompertzian model of human breast cancer growth Cancer Res 49 22 6443 6444
27. HE Ownby LD Roi RR Isenberg 1983 Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer Cancer 52 1 126 130
28. AE Papatestas GJ Lesnick G Genkins 1976 The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma Cancer 37 1 164 168
29. GA Rook 1999 Glucocorticoids and immune function Baillieres Clin Endocrinol Metab 13 4 567 581
30. S Rotstein H Blomgren B Petrini 1985 Blood lymphocyte counts with subset analysis in operable breast cancer. Relation to the extent of tumor disease and prognosis Cancer 56 6 1413 1419
31. W Ruka P Rutkowski J Kaminska 2001 Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance Ann Oncol 12 10 1423 1432
32. LM Thornton BL Andersen TR Crespin 2007 Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments Brain Behav Immun 21 2 185 194
33. SR Walsh EJ Cook F Goulder 2005 Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 3 181 184
34. Ware JE, Snow KK, Kosinski M (2000) SF-36 health survey: manual and interpretation guide. QualityMetric Incorporated, Lincoln
35. RH Whitehead J Thatcher C Teasdale 1976 T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro Lancet 14 1 330 33
36. C Wiltschke M Krainer AC Budinsky 1995 Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study Br J Cancer 71 1292 1296
37. S Yamasaki N Kan T Harada 1993 Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy. Breast Cancer Res Treat 26 1 55 65